These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4973804)

  • 21. [Bacillary dispersions in the lymphatic system during chronic pulmonary tuberculosis. (Histo-bacteriological studies)].
    Rossi P; Schmid G; Sternini M
    Ann Ist Carlo Forlanini; 1966; 26(4):493-507. PubMed ID: 4966441
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogeneity of drug-resistant strains of Mycobacterium tuberculosis].
    Belogurova VP
    Probl Tuberk; 1970; 48(9):76-9. PubMed ID: 4996497
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical research: course of pulmonary tuberculosis caused by polyresistant Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P
    Ann Ist Carlo Forlanini; 1969; 29(4):330-8. PubMed ID: 5004331
    [No Abstract]   [Full Text] [Related]  

  • 24. [Primary resistance of tubercle bacillus to standard drugs (incidence in Recife)].
    Magalhães M
    Rev Bras Med; 1969 Jul; 26(7):395-7. PubMed ID: 4981470
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of laboratory and clinical antitubercular agent sensitivity tests].
    Popovic J; Praso R; Stosic Z; Davidovic C
    Plucne Bolesti Tuberk; 1971; 23(4):333-8. PubMed ID: 5004987
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemotherapy of chronic pulmonary tuberculosis with polyresistant bacteria with reference to ethambutol and capreomycin.
    Radenbach KL
    Scand J Respir Dis Suppl; 1968; 65():195-206. PubMed ID: 4978461
    [No Abstract]   [Full Text] [Related]  

  • 27. [Drug resistance of Mycobacterium tuberculosis and its significance in the hospital practice].
    Rudoĭ NM
    Probl Tuberk; 1996; (3):6-8. PubMed ID: 8754863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Response of Mycobacteria tuberculosis isolated from chronic patients to single or combined drugs].
    Fanea E; Vaida T; Buzilă A; Bukşe E; Câmpeanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):335-42. PubMed ID: 6304848
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on tubercle bacilli resistant to secondary drugs in the resected specimens and sputum of pulmonary tuberculosis patients].
    Kameda K; Kudo S; Iwai K; Ushikubo K
    Kekkaku; 1970 Sep; 45(9):283-7. PubMed ID: 4989932
    [No Abstract]   [Full Text] [Related]  

  • 30. [Resistance and virulence of mycobacteria. Clinical and experimental studies].
    Lucchesi M
    Ftiziologia; 1971; 20(4):401-4. PubMed ID: 5005707
    [No Abstract]   [Full Text] [Related]  

  • 31. [Primary resistance in childhood. Correlation of infectious source with those exposed to infection].
    Silveira J; Medeiros S
    Torax; 1971; 20(1):113-6. PubMed ID: 5003925
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bacteriological considerations of multiple drug resistant bacilli].
    Shinoda A
    Kekkaku; 1971 Jan; 46(1):25-7. PubMed ID: 4993894
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of secondary chemoresistance of Koch bacillus at the present time].
    Jemna I; Lego I
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(4):243-4. PubMed ID: 6278569
    [No Abstract]   [Full Text] [Related]  

  • 34. Is second-line anti-tuberculosis drug susceptibility testing reliable?
    Kim SJ; Espinal MA; Abe C; Bai GH; Boulahbal F; Fattorin L; Gilpin C; Hoffner S; Kam KM; Martin-Casabona N; Rigouts L; Vincent V
    Int J Tuberc Lung Dis; 2004 Sep; 8(9):1157-8. PubMed ID: 15455606
    [No Abstract]   [Full Text] [Related]  

  • 35. [Main sources of the formation of contingents of tuberculosis patients with drug-resistant or sensitive Mycobacterium tuberculosis isolates].
    Zhukova MP
    Probl Tuberk; 1998; (4):4-5. PubMed ID: 9771024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mycobacteria resistance in coniotuberculosis].
    Beskrovnyĭ PS; Varenko IuS; Tkachenko LA
    Vrach Delo; 1982 Jul; (7):87-8. PubMed ID: 6814066
    [No Abstract]   [Full Text] [Related]  

  • 37. [Aspects of chemoresistance of Koch bacillus in the period 1971-1980 in the Constanţa tuberculosis outpatient clinic].
    Toldişan V; Didilescu C; Filip G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(1):53-7. PubMed ID: 6312536
    [No Abstract]   [Full Text] [Related]  

  • 38. [Biological properties of Mycobacterium tuberculosis in relation to sensitivity to antibacterial preparations].
    Gol'shevskaia VI; Grishina TA; Karpenko OL; Safonova SG; Grishina TD
    Probl Tuberk; 1995; (4):37-40. PubMed ID: 7567869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Advances in the treatment of pulmonary tuberculosis in children].
    Alcaide Megias J; Altet Gómez MN
    An Esp Pediatr; 1983 Sep; 19 Suppl 19():12-7. PubMed ID: 6419658
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factors affecting the efficacy of the treatment of tuberculosis patients discharging drug-resistant mycobacteria].
    Fomicheva NI; Terentieva AS
    Probl Tuberk; 1981 Dec; (12):23-6. PubMed ID: 6801645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.